ProCE Banner Activity

Conversations on Healthy Aging With HIV

Multimedia

Learn about medical and nonmedical challenges encountered by aging PWH—including subgroups of older patients such as women and people in resource-limited settings—and hear potential solutions in this lively panel discussion by expert healthcare professionals and patient advocates.

Released: September 23, 2022

Expiration: September 22, 2023

Share

Faculty

Jonathan Appelbaum

Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Florida State University College of Medicine
Tallahassee, Florida

Lydia Mungherera

Lydia Mungherera, MBChB

Executive Director, The Mamas Club Uganda
Co-Founder, The Global Athena Network
Member, The International Community of Women Living With HIV
Commissioner, Uganda AIDS Commission
Kampala, Uganda

Cristina Mussini

Cristina Mussini, MD

Director of Infectious Diseases Clinics
Professor of Infectious Diseases
University of Modena School of Medicine
Modena, Italy

Dorothy Onyango

Dorothy Onyango

Chief Executive Officer, Women Fighting AIDS in Kenya
Founding Member, International Community of Women Living With HIV
Former Chair, Pan African Womens Coalition
Former Board Member, Kenya National AIDS Council
Nairobi, Kenya

Melanie Reese

Melanie Reese

Subject Matter Expert, HIV Aging
Technical Expert Panel
Health Resources and Services Administration
HIV/AIDS Bureau
Baltimore, Maryland

Marc Thompson

Marc Thompson

Expert Patient
London, England

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

ViiV Healthcare

Learning Objectives

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Program Director Disclosure

Program Director

Jonathan Appelbaum, MD, FACP, AAHIVS

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Florida State University College of Medicine
Tallahassee, Florida

Jonathan Appelbaum, MD, FACP, AAHIVS:consultant/advisor/speaker: Merck, Theratechnologies, ViiV Healthcare.

Faculty Disclosure

Primary Author

Lydia Mungherera, MBChB

Executive Director, The Mamas Club Uganda
Co-Founder, The Global Athena Network
Member, The International Community of Women Living With HIV
Commissioner, Uganda AIDS Commission
Kampala, Uganda

Lydia Mungherera, MBChB, has no relevant financial relationships to disclose.

Cristina Mussini, MD

Director of Infectious Diseases Clinics
Professor of Infectious Diseases
University of Modena School of Medicine
Modena, Italy

Cristina Mussini, MD:consultant/advisor/speaker: AbbVie, Angelini, Gilead Sciences, Janssen, MSD, Pfizer, Roche, ViiV Healthcare; researcher: Gilead Sciences, Janssen, MSD, ViiV Healthcare.

Dorothy Onyango,

Chief Executive Officer, Women Fighting AIDS in Kenya
Founding Member, International Community of Women Living With HIV
Former Chair, Pan African Womens Coalition
Former Board Member, Kenya National AIDS Council
Nairobi, Kenya

Dorothy Onyango has no relevant financial relationships to disclose.

Melanie Reese,

Subject Matter Expert, HIV Aging
Technical Expert Panel
Health Resources and Services Administration
HIV/AIDS Bureau
Baltimore, Maryland

Melanie Reese has no relevant financial relationships to disclose.

Marc Thompson,

Expert Patient
London, England

Marc Thompson has no relevant financial relationships to disclose.

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer Blanchette, PhD, has no relevant financial relationships to disclose.

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant financial relationships to disclose.

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King, MA, has no relevant financial relationships to disclose.

Jacqueline Meredith, PharmD, BCIDP

Scientific Director

Jacqueline Meredith, PharmD, BCIDP, has no relevant financial relationships to disclose

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no relevant financial relationships to disclose.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant financial relationships to disclose.

Julie Skowronski, FNP-BC

Julie Skowronski, NP, has no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.